ArticlesLast Updated: October 3, 2026
We get this question every week, usually from a woman who has used relaxers since she was a girl and has just been handed a cancer diagnosis. The honest answer is that qualifying comes down to three things: what you were diagnosed with, how long and how often you used the products, and whether your deadline has run. Here is how we evaluate each one, and what the 12,381 women already in the federal case had to show.
1. A Qualifying Diagnosis
The hair relaxer litigation (MDL 3060, before Judge Mary Rowland in the Northern District of Illinois) is built on the 2022 NIH Sister Study, which found that women who used chemical straighteners more than four times a year had roughly double the risk of uterine cancer. The diagnoses the court and the science support most strongly are:
- Uterine cancer (including endometrial cancer and uterine sarcoma), the core claim in the MDL
- Ovarian cancer, supported by earlier Sister Study findings on straightener use
- Endometrial cancer, which is the most common form of uterine cancer and is treated as part of that group
Uterine fibroids and endometriosis come up often, and we take those cases. We will also tell you plainly that they face a harder causation road than the cancer cases, and the bellwether trials the court is preparing are cancer cases. If your diagnosis is fibroids that required a hysterectomy or myomectomy, call us; how strong that case is depends on your records, and that is a conversation, not a form.
2. Regular, Long-Term Product Use
The study threshold was more than four uses a year. In practice, the women whose cases are strongest used relaxers regularly for years, often starting as children, and can name the products. The brands in the litigation include L’Oréal’s Dark & Lovely and SoftSheen-Carson lines, Revlon’s relaxers, Strength of Nature (Just for Me, Motions, African Pride), and Namasté Laboratories’ ORS Olive Oil products, among others. You do not need receipts. You need to be able to say, honestly and consistently, what you used, roughly how often, and for how long, because that is what the plaintiff fact sheet asks and what the defense will test in deposition.
Salon application counts. So does home use. What matters is the chemical exposure, not who applied it.
3. A Deadline That Has Not Run
This is where women lose cases they would otherwise win. Each state sets its own limit, and the clock usually starts when you knew or reasonably should have known that the diagnosis might be connected to the product, not on the date of diagnosis itself. The rough guide:
- Alabama: generally two years
- Georgia: generally two years
- Tennessee: one year, the shortest in the region
- North Carolina and Washington, D.C.: generally three years
Do not assume you are too late, and do not assume you have plenty of time. The discovery rule cuts both ways, and the only way to know where you stand is to have someone apply your state’s law to your dates.
Brands Named in the Litigation
You do not have to match a product on this list to have a claim, and the list is not exhaustive — manufacturers have been added and dismissed as the litigation has developed, and product lines change hands. It is a memory aid. Most women recognise a line or two and work backwards from there.
| Manufacturer | Relaxer lines commonly identified |
|---|---|
| L’Oréal USA / SoftSheen-Carson | Dark & Lovely, Optimum |
| Strength of Nature Global | Just For Me, Motions, African Pride, Soft & Beautiful |
| Namasté Laboratories | Organic Root Stimulator (ORS) Olive Oil |
| Revlon | Revlon relaxer lines. Recovery against Revlon is limited to insurance because of its bankruptcy. |
| John Paul Mitchell Systems | Named as a defendant manufacturer |
| Wella Operations US | Named as a defendant manufacturer |
| Others named | Avlon, Advanced Beauty, House of Cheatham, Dudley Beauty, Dermoviva |
Who Does Not Qualify
This gets said less often than it should be, so here it is plainly. Four situations usually mean no case, or a much harder one.
No qualifying diagnosis. The consolidated litigation is built around uterine cancer, endometrial cancer and ovarian cancer. Claims resting only on uterine fibroids or endometriosis are treated separately and are not part of the bellwether group being worked up for trial. That does not make them worthless, but it does mean they sit on a different and slower track.
The filing deadline has already run. This is the most common reason a real injury goes uncompensated. The clock is set by state law and by when you knew, or reasonably should have known, that a product may have been involved. It is worth having checked even if you assume you are too late, because the discovery rule moves the starting line more often than people expect.
Brief or very distant use. The causation theory depends on sustained exposure. Someone who used a relaxer a handful of times decades ago and was diagnosed recently has a genuinely difficult case, and you should be told that rather than signed up.
No ability to identify the products, even approximately. You do not need receipts. You do need to be able to say what you used and roughly when. If you cannot get anywhere near that, the plaintiff fact sheet becomes very hard to complete truthfully.
One caution in the other direction: a firm that signs you up without asking about any of this is not doing you a favour. The screening questions are the point.
What Happens After You Call
The first conversation is a screening one: diagnosis and date, treatment, which products and for how long, and where you have lived. It takes a while and it is meant to. If the claim looks viable, you sign an authorization so the medical records can be pulled and read — the pathology report is what actually establishes the diagnosis, and no claim moves without it.
Not every screened claim gets filed. Records sometimes show a different cancer type than the client understood, or a date that puts the claim outside the deadline. That review happens before filing, not after.
If the case is filed, it joins MDL 3060 in the Northern District of Illinois for pretrial purposes. You then complete a plaintiff fact sheet within the period the court sets. Take that document seriously: across mass torts generally, incomplete and late fact sheets are one of the largest sources of dismissal, and those dismissals are avoidable. After that, the case waits while the bellwether group is worked up — which is the honest answer to how long this takes.
What You Will Be Asked to Provide
Medical records confirming the diagnosis and treatment, a product-use history, and basic biographical information. The MDL uses a standardized plaintiff fact sheet, and the court has started dismissing cases where it was never completed, so this is not paperwork you can put off after filing. We gather the records; you answer the questions.
Where the Case Stands
As of the Judicial Panel’s October 1, 2026 report, 12,381 cases are pending in the MDL. On September 1 the court trimmed the bellwether pool from ten cases to five and extended discovery against the later-added defendants through July 2027. The general-causation expert rulings are still pending, the first federal trial has been reported for January 2027, and no global settlement exists. Women who file now are positioned ahead of any settlement framework; the details are on our hair relaxer lawsuit update page.
Talk to Us
Fob James Personal Injury Lawyers represents women in Alabama, Georgia, Tennessee, North Carolina, and Washington, D.C. in the hair relaxer litigation, on a 33–40% contingency fee, with no fee unless we recover. Call (205) 407-6009 or use the confidential intake form. Ten minutes on the phone answers the qualification question for most callers.
Frequently Asked Questions
Do I need proof of which relaxer I used?
Not receipts. A consistent, honest account of the products, the years, and the frequency is what the fact sheet requires. Photos, salon records, or old product containers help but are not required.
I used relaxers but have not been diagnosed with anything. Can I file?
No. The litigation is for women with a qualifying diagnosis. If you are worried about your risk, talk to your doctor about screening; if you are later diagnosed, call us then.
Has anyone received a settlement from the hair relaxer lawsuit yet?
No. As of October 2026, no hair relaxer case has publicly settled or reached a jury verdict. Any dollar figure you see quoted online is a guess.
Related: Alabama Hair Relaxer Lawsuit · Georgia Hair Relaxer Lawsuit · Tennessee Hair Relaxer Lawsuit · Hair Relaxer Lawsuit Update · When Will the Hair Relaxer Lawsuit Be Settled?
Does it cost anything to find out if I qualify?
No. The screening conversation and the review of your records cost you nothing, and these cases are handled on a contingency basis, meaning a fee is owed only out of a recovery. If there is no recovery there is no fee. Ask any firm you speak with to put its fee terms in writing before you sign, and ask specifically whether case costs are treated separately from the fee.
My mother died of uterine cancer. Can I file for her?
Often yes. A claim does not die with the person who was injured — it is brought by the estate, usually through the personal representative, and in some states by specific surviving family members. Who has standing and which deadline applies are both state-law questions, and the wrongful death deadline is frequently different from the personal injury one, so this is worth checking early rather than late. You will need the death certificate and the underlying medical records in addition to the usual product history.
Fob James, IV
Fob James obtained a B.S., in software engineering from Auburn University and then continued his education by getting his J.D. from Vanderbilt University School of Law. After working for a large national firm for several years, Fob found that his passion was fighting for individuals who have been seriously injured or wronged by others. Fob believes that the jury is the great equalizer to the power and influence that large corporations have in society. Many of Fob’s cases are high profile and have been featured in, among others: Bloomberg News, PlanAdvisor, AL.com, PlanSponsor, InsuranceJournal, and BusinessInsider. For his work in obtaining numerous multi-million dollar outcomes for his clients, Fob has been recognized by: National Trial Lawyers Top 100, SuperLawyers Rising Star (2020-2026), Birmingham Business Journal Who’s Who in Law (2023-2025), and TrustAnalytica – Top Personal Injury Lawyers in Alabama.